Therapy Area Pipeline Reports contain detailed information on drug pipelines by therapeutic indication. Each report provides insight into the pipeline status of a specific therapeutic indication by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the reports
Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering
activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20
companies with products in the early stage of development and the top 20 companies with products in the late stage
of development. Finally, each report also provides a comparison with other major indications in the disease hub
based on Marketed Products vs. Pipeline Products.